CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
The FDA has approved the Siemens Advia Centaur HIV Ag/Ab Combo (cHIV) assay. This latest addition to the Advia Centaur infectious disease menu, which also includes tests for hepatitis A, B, and C, eHIV, syphilis, and other infectious disease assays, enables laboratories to further consolidate their testing to enhance efficiencies. It is designed to simultaneously detect the presence of the HIV viral protein (p24 antigen) and the antibodies produced in response to the HIV (HIV-1 or HIV-2) viral infection. The ability to detect the antigen and the antibody may enable earlier detection of acute infection, allowing both clinical management and behavior modification that may reduce transmission.
Siemens Healthcare, 914-524-2844